Donor gene clue to kidney transplant rejectionNews-Medical.netBy Lauretta Ihonor, medwireNews Reporter. Genetic study results show that long-term kidney transplant rejection risk may be increased if the organ donor has a variant form of the multidrug r…

NIH $20 million transplant grant aims at better drugs, long-term organ toleranceEmory University News and EventsAlthough belatacept avoids some of the toxicity of earlier transplant drugs, it is associated with higher rates of reversible acute rejectio…

Graft rejection more likely in eyes with corneal edemaHealioThe analysis used data from the prospective Cornea Donor Study to determine the effect of donor and recipient factors on corneal allograft rejection. The study examined 1,090 patients who unde…

General Surgery NewsSleeve Improves Transplant Candidacy in Morbidly ObeseGeneral Surgery NewsBy the time of their transplant, their mean BMI had dropped to 31 kg/m 2. Transplant patients did not experience negative effects from the bariatric surgery. …

Infection-Related Hospitalizations Common Post-TransplantRenal and Urology NewsThe presence of diabetes mellitus before transplantation and allograft rejection were the major risk factors associated with hospitalization secondary to an infectious cause…

In-PharmaTechnologist.comSamsung halts biosimilar rituximab trial on regulatory concernsIn-PharmaTechnologist.comThe JV formed through the deal is focused on developing biosimilar versions of marketed products which – evidently – included a version of …

Renowned Einstein Immunologist RememberedBioscience Technology"Since 1965, when he first joined the Einstein faculty, Stan quietly and persistently pursued the mechanisms of T-cell activation and helped define the immunological basis for organ tra…

4 Biotechs Targeting FibrosisSeeking AlphaLastly, the company plans to file an IND for the prevention of renal transplant rejection by the end of 2012. Risk Factors – For a small, speculative biotech that trades over the counter, there are many real ri…

'Lungapalooza' Sunday on Duke campusDurham Herald Sun“Amber was a visionary and a fighter committed to advancing research that will eliminate lung transplant rejection,” said Jeff Goldstein, LTF's Founder, who is also a bi-lateral lung …

NIH $20 Million Transplant Grant Aims at Better Drugs and Long-term Organ …HealthNewsDigest.comAlthough belatacept avoids some of the toxicity of earlier transplant drugs, it is associated with higher rates of reversible acute rejection. And because …